Months of entry
Stratified Medicine holds huge potential in the timely development of new treatments for human disease. It is among the most important concepts to emerge in 21st century clinical science and will be a crucial component of the global drive to increase the efficacy, safety and cost effectiveness of new treatments. This new taught postgraduate Masters programme draws on the current and future needs of the Life Sciences sector, to create a highly skilled workforce. It harnesses Scotland’s strengths in Stratified Medicine, Clinical Trials, Bioinformatics and Pharmacogenomics to provide focused training which integrates basic and clinical sciences, and equips students with grounding in the essential skills required to design, execute and evaluate modern clinical interventions.
- The programme will cover the principles which underpin the emerging science at the interface between genetics and pharmacology and the clinical evaluation of the resultant new medicines, taught by internationally recognised experts
- The aim of this programme is to train researchers who can break down the barriers that currently prevent discoveries at the bench from being translated into treatments at the bedside
- University of Glasgow is rated in the top 1% of universities worldwide, and has a global reputation in the field of clinical trials and stratified medicine. You will be taught by a multidisciplinary team of world leading scientists and clinicians within the College of Medical, Veterinary and Life Sciences
- Students will gain an understanding of statistical methods used to evaluate the efficacy and cost-effectiveness of new treatments
- Students on the programme will undergo theoretical and practical training in state-of-the-art research processes available to researchers in Glasgow, enabling an appreciation of how to apply novel stratified approaches, together with clinical pharmacological, regulatory and ethical principles to the optimisation of future clinical research and therapeutic practice.
- We have excellent opportunities to engage with industrial and clinical scientists, with guest lecturers from the pharmaceutical industry, medical diagnostic laboratories and bioscience business which will help you understand the science, methodology and terminology used by scientists and clinicians from different disciplines. You will learn to communicate effectively in a multidisciplinary environment, critically evaluate a wide range of scientific data and research strategies and learn how to make a significant contribution to research and treatment in the 21st century
- You will be taught by a multidisciplinary team of world leading scienctists and clinicians within the College of Medical, Veterinary and Life Sciences
- Students will learn how all of the above techniques are applied by academic and industrial researchers in the development of new medicines
- Scholarships available
Students will undertake core courses which will account for 90 credits and a further 30 credits from options which will enable students to personalise their degree to better align it with their future career aspirations. Students will also be offered a choice of project.
- Topics in Therapeutics - general topics and cardiovascular disease
- Pharmacogenomics and Molecular Medicine - fundamentals of molecular medicine
- Medical Statistics 1
- Evidence based research in medicine
- Drug disposition
- Clinical trials: principles and methods.
- Pharmacogenomics & molecular medicine - applied pharmacogenomics and molecular medicine
- Topics in therapeutics - commonly used drugs
- Pharmaceutical medicine
- Medical statistics 2
- Established and novel techniques in cardiovascular & medical sciences research.
Project and Assessment
The project will account for the remaining 60 credits. The programme will include an opportunity for all students to present the outcomes of their projects to an audience of other students and academics. Assessment will consist of submission of a Dissertation and a viva examination.
Graduates of this programme will be competitive applicants for the positions in the commercial life sciences sector, or for PhD study in an academic or combined commercial / academic environment.
Information for international students
For applicants whose first language is not English, the University sets a minimum English Language proficiency level.
International English Language Testing System (IELTS) Academic module (not General Training)
- overall score 6.5
- no sub-test less than 6.0
- or equivalent scores in another recognised qualification:
Common equivalent English language qualifications
All stated English tests are acceptable for admission for both home/EU and international students for this programme:
- ibTOEFL: 90; no sub-test less than:
- Reading: 20
- Listening: 19
- Speaking: 19
- Writing: 23
- CAE (Cambridge Certificate of Advanced English): 176 overall; no sub-test less than 169
- CPE (Cambridge Certificate of Proficiency in English): 176 overall; no sub-test less than 169
- PTE Academic (Pearson Test of English, Academic test): 60; no sub-test less than 59
- Trinity College London Integrated Skills in English: ISEII at Distinction with Distinction in all sub-tests
For international students, the Home Office has confirmed that the University can choose to use these tests to make its own assessment of English language ability for visa applications to degree level programmes. The University is also able to accept an IELTS test (Academic module) from any of the 1000 IELTS test centres from around the world and we do not require a specific UKVI IELTS test for degree level programmes. We therefore still accept any of the English tests listed for admission to this programme.
The University of Glasgow accepts evidence of the required language level from the English for Academic Study Unit Pre-sessional courses. We also consider other BALEAP accredited pre-sessional courses:
Fees and funding
Qualification and course duration
Course contact details